---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-115921"
form_type: "8-K"
ticker: "INMB"
cik: "0001711754"
company_name: "Inmune Bio, Inc."
filed_at: "2025-11-28T23:59:59+00:00"
generated_at: "2026-05-16T16:11:46.392504+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# INmune Bio enters new employment agreements with CEO, CFO, and CSO

## Summary
- CEO David Moss: $500,000 base salary, 50% bonus target, option for 800,000 shares.
- CFO Cory Ellspermann: $275,000 base salary, 40% bonus target, option for 300,000 shares.
- CSO Mark Lowdell: £300,000 base salary, up to 20% annual bonus, 18-month severance.
- Severance for Moss/Ellspermann: 18 months base salary, prorated bonus, and COBRA payments.
- New agreements effective November 1, 2025; all include change-of-control equity acceleration.

## SEC filing metadata
- accession: 0001213900-25-115921
- form_type: 8-K
- ticker: INMB
- cik: 0001711754
- company_name: Inmune Bio, Inc.
- filed_at: 2025-11-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1711754/000121390025115921/0001213900-25-115921-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1711754/000121390025115921/ea0267546-8k_inmune.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-115921
- JSON: https://secwatch.observer/filing/0001213900-25-115921.json
- Plain text: https://secwatch.observer/filing/0001213900-25-115921.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.